Literature DB >> 11591272

Cryopreservation of human oocytes.

G Coticchio1, S Garetti, M A Bonu, A Borini.   

Abstract

Cryopreservation is a well established technique by which preimplantation stage embryos can be stored for later use. However, it would be preferable to cryopreserve unfertilized oocytes to overcome the problems related to the ethical and legal status of the embryo. This procedure has been successful in mice, but attempts to extend this approach to other species have been less successful. In human in vitro fertilization (IVF) in particular, very few live births have been reported after the cryopreservation of oocytes. The reason for this lack of success is unclear. The widespread contention that compromised oocyte viability originates principally from damage to the meiotic spindle induced by cryopreservation conditions is unproven. The treatment of large groups of women has shown that pregnancies derived from stored oocytes can be achieved in a reproducible fashion, although success rates are still lower than those derived from frozen embryos. To date, human oocytes have been stored largely by applying methods originally designed for cleaving embryos. Therefore, it is reasonable to envisage that appropriate modification of current freezing techniques will increase survival rates and make oocyte storage an important option in IVF treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11591272     DOI: 10.1080/1464727012000199222

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  2 in total

Review 1.  Oocyte cryopreservation: is it time to remove its experimental label?

Authors:  Nicole Noyes; Jeffrey Boldt; Zsolt Peter Nagy
Journal:  J Assist Reprod Genet       Date:  2010-02-06       Impact factor: 3.412

2.  Optimized protocol for cryopreservation of human eggs improves developmental competence and implantation of resulting embryos.

Authors:  Cassie T Wang; Lifeng Liang; Craig Witz; Dan Williams; Jason Griffith; Josh Skorupski; Ghassan Haddad; Jimmy Gill; Weihua Wang
Journal:  J Ovarian Res       Date:  2013-02-13       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.